Ariad Pharmaceutical's shares gain

30-11-2013 Boston GlobeComments (0)

Ariad PharmaceuticalsBiotechnology

Shares of Ariad Pharmaceuticals rose Friday. The Cambridge biotech learned last week that European regulators recommended continued use of its leukemia drug Iclusig, though US sales were suspended due to safety concerns. The European vote of ...

Read more on Boston Globe

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top